Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maze Therapeutics (MAZE) Capital Expenditures (2024 - 2026)

Maze Therapeutics' Capital Expenditures history spans 3 years, with the latest figure at $6000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 97.99% to $6000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$288000.0, a 120.59% decrease, with the full-year FY2025 number at $5000.0, down 99.56% from a year prior.
  • Capital Expenditures hit $6000.0 in Q1 2026 for Maze Therapeutics, up from -$755000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for MAZE hit a ceiling of $605000.0 in Q4 2024 and a floor of -$755000.0 in Q4 2025.
  • Historically, Capital Expenditures has averaged $128666.7 across 3 years, with a median of $103000.0 in 2024.
  • The widest YoY moves for Capital Expenditures: up 536.17% in 2025, down 224.79% in 2025.
  • Tracing MAZE's Capital Expenditures over 3 years: stood at $605000.0 in 2024, then tumbled by 224.79% to -$755000.0 in 2025, then surged by 100.79% to $6000.0 in 2026.
  • Business Quant data shows Capital Expenditures for MAZE at $6000.0 in Q1 2026, -$755000.0 in Q4 2025, and $68000.0 in Q3 2025.